Cell and Gene Outsourcing
-
Viral Vector Manufacturing: Improve Efficiency With A Platform Approach
9/25/2023
Learn more about the platform-based scalable suspension process for LVV production and how it is impacting CGTs advancing toward commercialization.
-
Optimization-By-Design — A Critical Factor In Viral Vector Scale Up
12/14/2023
Learn how leveraging the expertise and capabilities of an experienced partner is a key factor in optimizing AAV processes using Design of Experiment (DoE), thereby reducing variability and risk.
-
Mastering The Journey From Initial Method Transfer To Successful Lot Release For Cell & Gene Therapies
7/11/2024
View the webinar and learn how efficient project management and optimized communication are cornerstones of a successful transfer process.
-
Selecting Containers For Sensitive And Costly Cell & Gene Therapies
Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.
-
Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service
11/17/2021
The company’s wide-ranging expertise and vertically integrated service offering translate to the ability to rapidly execute multiple projects from its state-of-the-art cGMP facilities while ensuring full process and product compliance at all stages of research, development and commercial manufacturing.
-
Critical Supply Chain And Logistics Considerations For Cell And Gene Therapy Management
8/30/2024
Explore the unique challenges and complexities involved in key CGT logistics areas like donor and patient accessibility, critical raw materials management, and innovative temperature control equipment.
-
Keys To A Successful cGMP Manufacturing Operation Delivering CGTs
Uncover the secrets behind successes in commercializing and producing commercial cell and gene therapies, including establishing standards of every day, manufacturing operational excellence.
-
Meeting Needs And Exceeding Expectations Worldwide
10/16/2024
Whether you are looking to optimize your existing formulations or require full-scale manufacturing solutions, Boehringer Ingelheim BioXcellence™ is dedicated to helping you realize your vision and deliver impactful therapies.
-
Quality Agreements: Defining Governance In CDMO Partnerships
5/15/2024
Quality agreements serve a critical role within a CDMO-Sponsor partnership. Review the importance of aligning objectives, quality standards, and compliance frameworks to establish a robust foundation.
-
Preparing For FDA Pre-Approval Inspection: Quality And Regulatory Topics
Consider these strategies for meeting quality and regulatory requirements in cell and gene therapies that can also help to identify issues early, reduce risks, and prevent delays and rework.